Beijing Choice Electronic Technology Co., Ltd. v. Contec Medical Systems USA, Inc.

CourtDistrict Court, N.D. Illinois
DecidedJanuary 14, 2020
Docket1:18-cv-00825
StatusUnknown

This text of Beijing Choice Electronic Technology Co., Ltd. v. Contec Medical Systems USA, Inc. (Beijing Choice Electronic Technology Co., Ltd. v. Contec Medical Systems USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Beijing Choice Electronic Technology Co., Ltd. v. Contec Medical Systems USA, Inc., (N.D. Ill. 2020).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

BEIJING CHOICE ELECTRONIC ) TECHNOLOGY CO., LTD., ) ) Plaintiff, ) ) No. 18 C 825 v. ) ) Judge Sara L. Ellis CONTEC MEDICAL SYSTEMS USA, INC., ) and CONTEC MEDICAL SYSTEMS CO., ) LTD. ) ) Defendants. )

OPINION AND ORDER In this lawsuit, Plaintiff Beijing Choice Electronic Technology Co., Ltd. (“Choice”) alleges that Defendants Contec Medical Systems USA, Inc., and Contec Medical Systems Co., Ltd. (collectively, “Contec”) have infringed on Choice’s patents for a fingertip pulse oximeter and methods for updating the display mode of fingertip pulse oximeters. The parties now seek construction of several claims in the subject patent, U.S. Patent No. 8,639,398 (the “’308 patent”). The Court construes the disputed claims and provides its analysis as stated below. LEGAL STANDARD “Judicial ‘construction’ of patent claims aims to state the boundaries of the patented subject matter, not to change that which was invented.” Fenner Invs., Ltd. v. Cellco P’ship, 778 F.3d 1320, 1323 (Fed. Cir. 2015). Not all claims require construction, only those in dispute and only to the extent necessary to resolve the dispute. Vivid Techs., Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d 795, 803 (Fed. Cir. 1999). The Court’s inquiry begins by considering how a person of ordinary skill in the art (“POSITA”) would understand a claim term. Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed. Cir. 2005). A POSITA reads a term in the context of the claim itself as well as the entire patent, including the specification. Id. The Court’s analysis primarily relies on the intrinsic evidence, which “includ[es] the claims themselves, the specification, and the prosecution history of the patent.” Sunovion

Pharms., Inc. v. Teva Pharms. USA, Inc., 731 F.3d 1271, 1276 (Fed. Cir. 2013). The Court first reviews the language of the claims themselves, applying a “heavy presumption that claim terms take on their ordinary meaning as viewed by one of ordinary skill in the art.” Altiris, Inc. v. Symantec Corp., 318 F.3d 1363, 1369 (Fed. Cir. 2003) (citation omitted) (internal quotation marks omitted). The presumption of ordinary meaning prevails in all but two situations: (1) “when a patentee acts as his own lexicographer” or (2) “when the patentee disavows the full scope of the claim term in the specification or during prosecution.” Poly-Am., L.P. v. API Indus., Inc., 839 F.3d 1131, 1136 (Fed. Cir. 2016). “In most situations, an analysis of the intrinsic evidence alone will resolve any ambiguity in a disputed claim term.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1583 (Fed. Cir.

1996); see also Sunovion Pharms., 731 F.3d at 1276 (intrinsic evidence is “usually dispositive”). In such cases, “it is improper to rely on extrinsic evidence,” which includes dictionary definitions, expert testimony, and other “evidence that is external to the patent and file history.” Vitronics, 90 F.3d at 1583–84. The Court may consider extrinsic evidence, however, “if needed to assist in determining the meaning or scope of technical terms in the claims,” Pall Corp. v. Micron Separations, Inc., 66 F.3d 1211, 1216 (Fed. Cir. 1995), and to ensure that a construction “is not inconsistent with clearly expressed, plainly apposite and widely held understandings in the pertinent technical field,” Plant Genetic Sys., N.V. v. DeKalb Genetics Corp., 315 F.3d 1335, 1346 (Fed. Cir. 2003) (citation omitted). Extrinsic evidence is generally considered “less reliable than the patent,” Phillips, 415 F.3d at 1318, and “may not be used to vary or contradict the claim language” or “the import of other parts of the specification,” Vitronics, 90 F.3d at 1584. While the Court must construe claims in light of the specification, the Court cannot typically read limitations from the preferred embodiments or specific examples in the

specification into the claims. Enercon GmbH v. Int’l Trade Comm’n, 151 F.3d 1376, 1384 (Fed. Cir. 1998) (“This court has repeatedly stated that while claims are to be construed in light of the specification, they are not necessarily limited by the specification.”). Thus, while the Court may use a specification to aid in the interpretation of the claims, the Court may not use it as a source for adding extraneous limitations. Renishaw PLC v. Marposs Societa’ per Azioni, 158 F.3d 1243, 1249 (Fed. Cir. 1998) (“If we need not rely on a limitation to interpret what the patentee meant by a particular term or phrase in a claim, that limitation is ‘extraneous’ and cannot constrain the claim.” (citations omitted)). ANALYSIS I. Late Disclosure

Before reaching the substance of the parties’ arguments, the Court must address Choice’s procedural objection to Contec’s proposed construction of “power source” and “when the user presses a button.” Choice asks the Court to refrain from construing these terms because Contec belatedly disclosed its alternative constructions in violation of the Court’s deadlines.1 Choice argues that this prejudiced its ability to seek discovery related to these two terms, “such as certain designs and operations of the accused products.” Doc. 150 at 21. Choice also argues that construing these terms will waste resources because Contec has not certified that these terms are outcome-determinative pursuant to Local Patent Rule 4.1(b). Contec responds that these terms

1 The Court ordered the parties to disclose proposed claim constructions by May 15, 2019, and the Court ordered discovery closed by June 14, 2019. Contec did not disclose these terms until June 21, 2019, the due date of its opening claim construction brief. are outcome-determinative, and the Court must resolve disputes regarding the scope of the disputed claims. Choice did not renew its objection at the Markman hearing on September 6, 2019, and instead thoroughly addressed Contec’s proposed constructions through the expert witnesses and

during its argument. Additionally, further discovery related to Contec’s device would be of little value since “claims may not be construed by reference to the accused device.” NeoMagic Corp. v. Trident Microsystems, Inc., 287 F.3d 1062, 1074 (Fed. Cir. 2002). Thus, the Court is hard- pressed to find that the late disclosure prejudiced Choice to the point that it warrants ignoring Contec’s contentions. See Par Pharm., Inc. v. QuVa Pharma, Inc., 764 F. App’x 273, 278 n.6 (3d Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Neomagic Corporation v. Trident Microsystems, Inc.
287 F.3d 1062 (Federal Circuit, 2002)
Altiris, Inc. v. Symantec Corp., Defendant-Cross
318 F.3d 1363 (Federal Circuit, 2003)
Fenner Investments, Ltd. v. Cellco Partnership
778 F.3d 1320 (Federal Circuit, 2015)
Trustees of Columbia Univ. v. Symantec Corporation
811 F.3d 1359 (Federal Circuit, 2016)
Poly-America, L.P. v. Api Industries, Inc.
839 F.3d 1131 (Federal Circuit, 2016)
Nobel Biocare Services Ag v. Instradent USA, Inc.
903 F.3d 1365 (Federal Circuit, 2018)
Bradium Techs. LLC v. Andrei IANCU
923 F.3d 1032 (Federal Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Beijing Choice Electronic Technology Co., Ltd. v. Contec Medical Systems USA, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/beijing-choice-electronic-technology-co-ltd-v-contec-medical-systems-ilnd-2020.